Literature DB >> 16694760

INCREASED UROBILINOGEN EXCRETION AND ACUTE HEMOLYTIC ANEMIA IN PATIENTS TREATED WITH SULFAPYRIDINE.

L A Erf1, C M Mac Leod.   

Abstract

Entities:  

Year:  1940        PMID: 16694760      PMCID: PMC434978          DOI: 10.1172/JCI101146

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  6 in total

1.  Porphyrinuric action of drugs related to sulphanilamide. Comparison with reported toxicity, therapeutic efficiency and causation of methaemoglobinaemia. Definition of the structure responsible for porphyrinuric action.

Authors:  C Rimington; A W Hemmings
Journal:  Biochem J       Date:  1939-06       Impact factor: 3.857

2.  The role of the aromatic amino group in deranged pigment metabolism.

Authors:  G Brownlee
Journal:  Biochem J       Date:  1939-05       Impact factor: 3.857

3.  THE EXCRETION OF INTRAVENOUSLY INJECTED BILIRUBIN AS A TEST OF LIVER FUNCTION.

Authors:  G A Harrop; E S Barron
Journal:  J Clin Invest       Date:  1931-02       Impact factor: 14.808

4.  THE DETERMINATION OF SULFANILAMIDE.

Authors:  E K Marshall; J T Litchfield
Journal:  Science       Date:  1938-07-22       Impact factor: 47.728

5.  STUDIES OF UREA EXCRETION. II: Relationship Between Urine Volume and the Rate of Urea Excretion by Normal Adults.

Authors:  E Möller; J F McIntosh; D D Van Slyke
Journal:  J Clin Invest       Date:  1928-12       Impact factor: 14.808

6.  STUDIES OF UREA EXCRETION. III: The Influence of Body Size on Urea Output.

Authors:  J F McIntosh; E Möller; D D Van Slyke
Journal:  J Clin Invest       Date:  1928-12       Impact factor: 14.808

  6 in total
  1 in total

1.  Sulfonamide Compounds: Blood Changes Therefrom.

Authors:  C B Hendricks
Journal:  Cal West Med       Date:  1942-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.